Trastuzumab (or biosimilar): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Trastuzumab (or biosimilar)

• Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer
  NCT07393425 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
  NCT06649331 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
  NCT07220135 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations

Common questions

How many recruiting trials involve Trastuzumab (or biosimilar)?

3 recruiting trials across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.